Skip to main content
Equibles

Swiss National Bank

Bank

Position in IDYA — IDEAYA Biosciences, Inc.

CIK 1582202 ZURICH, V8
Back to IDYA Full portfolio

Position in IDYA

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$5,911,022
+$726,430 QoQ
Shares Held
158,600
+1.9% QoQ
Ownership
0.164%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#66
of 286 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IDYA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Swiss National Bank holds $1,800,323,370 across 152 Biotechnology names. IDYA ranks #49 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 717,440 $356,373,971
2 REGN
Regeneron Pharmaceuticals, Inc.
 293,020 $182,709,690
3 ALNY
Alnylam Pharmaceuticals, Inc.
 374,080 $112,609,302
4 RVMD
Revolution Medicines, Inc.
 456,331 $85,461,669
5 RPRX
Royalty Pharma plc
 1,159,800 $65,029,986
6 INSM
INSMED Inc
 593,512 $63,280,249
7 INCY
Incyte Corp
 476,874 $54,058,436
8 MRNA
Moderna, Inc.
 679,900 $47,613,397

All Filings in IDYA

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,911,022 158,600
2026-03-31 $5,184,592 155,600
2025-12-31 $5,379,092 155,600
2025-09-30 $4,157,688 152,800
2025-06-30 $3,169,816 150,800
2025-03-31 $2,470,104 150,800
2024-12-31 $3,844,720 149,600
2024-09-30 $4,216,608 133,100
2024-06-30 $4,378,217 124,700
2024-03-31 $4,888,232 111,400
2023-12-31 $3,027,858 85,100
2023-09-30 $2,886,860 107,000
2023-06-30 $2,427,550 103,300
2023-03-31 $1,139,590 83,000
2022-12-31 $1,686,176 92,800
2022-09-30 $1,353,244 90,700
2022-06-30 $880,440 63,800
2022-03-31 $713,922 63,800
2021-12-31 $1,399,488 59,200